Akèy › Epidermolysis Bullosa Dystrophica
Etid klinik pou Epidermolysis Bullosa Dystrophica ap rekrite nan Etazini
9 etid pou Epidermolysis Bullosa Dystrophica ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 28, 2026 · NCT06423573A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
Ap rekriteFaz 2
Laj 4 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06594393A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 14, 2026 · NCT07700966Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
Ap rekriteFaz 1/2
Laj 6 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT06834035Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 24, 2026 · NCT01019148A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
Ap rekriteFaz 3
6 Months · Tout sèks · Mizajou Mar 12, 2026 · NCT07016750A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
Ap rekriteEtid obsèvasyon
6 Months · Tout sèks · Mizajou Jul 2, 2025 · NCT06563414MSC EVs in Dystrophic Epidermolysis Bullosa
Ap rekriteFaz 1/2
6 Months · Tout sèks · Mizajou Jun 25, 2025 · NCT04173650Long-Term Follow-up Protocol
Ap rekriteEtid obsèvasyon
6 Months · Tout sèks · Mizajou Jun 8, 2021 · NCT04917887Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.